--- title: "Weekly Recap | MOBVISTA -2.26%, an up-then-down week" type: "News" locale: "en" url: "https://longbridge.com/en/news/305528552.md" description: "MOBVISTA closed the week at HK$9.93, down 2.26%, outperforming the Hang Seng Index by about 1.06 percentage points (the index fell 3.32% over the same period). The stock saw an up-then-down pattern: it opened Monday at HK$10.50 and ended that session at HK$10.72, climbed to a weekly high of HK$11.07 on Tuesday, then gave back gains over the next two sessions. Thursday’s low was HK$9.90 and the close came in at HK$9.93. Weekly amplitude was 11." datetime: "2026-11-14T05:14:51.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/305528552.md) - [en](https://longbridge.com/en/news/305528552.md) - [zh-HK](https://longbridge.com/zh-HK/news/305528552.md) generator: "portal-rs" --- # Weekly Recap | MOBVISTA -2.26%, an up-then-down week ## The Week MOBVISTA (1860.HK) closed the week at HK$9.93, down 2.26%, outperforming the Hang Seng Index by about 1.06 percentage points (the index fell 3.32% over the same period). The stock saw an up-then-down pattern: it opened Monday at HK$10.50 and ended that session at HK$10.72, climbed to a weekly high of HK$11.07 on Tuesday, then gave back gains over the next two sessions. Thursday’s low was HK$9.90 and the close came in at HK$9.93. Weekly amplitude was 11.14%, with average daily volume around 12.6m shares, roughly 17% above the median level. ## Key Events There were no company announcements or earnings releases during the week, so the event calendar was thin. The most relevant news item was an English-language report on Tuesday 10 November that Mobvista climbed 6% in Hong Kong trading, matching the intraday move toward the week’s high. A separate midday market note that day covered the Hang Seng Index edging up 49 points and pharma stocks rallying, but that was broader market backdrop rather than a company-specific driver. Overall, the week did not bring any fundamental change in the company’s story. ## Analyst Ratings As of 12 November 2026, 6 brokers cover the stock: 4 rate it buy, 1 rate it overweight, and 1 has no opinion. No broker rates it hold, underweight or sell. The consensus recommendation is strong buy, with a consensus target price of HK$15.94, about 60.5% above the last close. Targets are wide: the highest is HK$19.39 and the lowest is HK$5.51. Within the media sector (8 names), the stock ranks 2nd by rating. ## The Week Ahead Next week brings two Hong Kong macro releases: the unemployment rate on Tuesday 17 November (prior 3.9) and the composite CPI on Friday 20 November (prior 1.9). The company has no scheduled earnings or major events of its own, so attention will be on broad market sentiment and whether the stock can hold near the HK$9.9 level. ## In Short The week’s mixed picture looks like this: the analyst side is positive, with a strong buy consensus and target price more than 60% above spot, but the price failed to rebuild momentum after the mid-week high. In the latest session, large-lot orders were slight net buyers while medium and small orders were net sellers. Valuation sits at about 4.93x PB and about 28.2x trailing P/E, in the neutral-to-rich zone. The near-term question is whether the stock holds around HK$9.9, and whether next week’s macro data shifts sector sentiment. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [01860.HK](https://longbridge.com/en/quote/01860.HK.md) ## Related News & Research - [Mobvista Holds Extraordinary General Meeting](https://longbridge.com/en/news/306090495.md) - [What ZhongAn Holders Got Wrong Before The Slide](https://longbridge.com/en/news/305557631.md) - [Lean and Mathlib Communities Verify Levent Alpöge’s Riemann Hypothesis Proof](https://longbridge.com/en/news/306379574.md) - [Mobvista files HKEX next-day disclosure return for share buyback at HKD 10.15 each](https://longbridge.com/en/news/298317752.md) - [CEO & Chairman Of Legion Consortium Sold 32% Of Their Shares](https://longbridge.com/en/news/306378655.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**